Gilad&Gilad announces AgmaSet reviewed in ‘Breakthroughs in Natural Healing 2012’

May 13, 2012 — Gilad&Gilad announces the inclusion of a chapter on “The New Supplement That Soothes Sciatica”, an overview on its novel nutraceutical for nerve pain-free functions, AgmaSet (Neurofencine), in the book Bottom Line’s Breakthroughs in Natural Healing 2012. *†

Bottom Line’s Breakthroughs in Natural Healing 2012 is written by Bill Gottlieb, an author and freelance journalist specializing in health. His Bottom Line’s yearly book series has sold hundreds of thousands copies. This proves that the exceptional effectiveness of AgmaSet for pain-free nerve functions continues to gain acceptance with clients.

The chapter summarizes the science and clinical studies behind G-agmatine, the neuroprotective ingredient in AgmaSet. G-agmatine is a widespread natural amino acid metabolite found in low amounts in various plant, fish and meat foodstuff. In high amounts it acts as a shotgun targeting multiple molecular mechanisms critical for healthy nerve functions including: key neurotransmitters; potassium and calcium ion channels; molecule membrane transporters; nitric oxide (NO) production; polyamine metabolism; and extracellular proteins.

AgmaSet, by fortifying the diet with high effective amounts of G-agmatine, affords nerve pain-free functions, normal sensory functions and nerve-dependent muscle strength. An estimated 3 to 6 million Americans cope everyday with circumstances that pose threat to healthy nerve functions. AgmaSet, therefore, has wide implications for multitude of people whose need for a dietary supplement, which can afford a superior solution for a safer (lacking adverse side effects) and more effective alternative for nerve resilience and nerve pain-free functions, remained unmet until now.

AgmaSet is manufactured in the USA under the highest quality standards and regulations and is available only from Gilad&Gilad. The product is sold direct to consumers online, to practicing healthcare professionals, to pharmacies, health stores, and to distributors.

Source: Gilad&Gilad, fornervehealth.com

*The language used in this Press Release conforms to all relevant FDA and FTC regulations.† The statements in this Press Release have not been evaluated by the Food and Drug Administration. The Products mentioned in this Press Release are not intended to diagnose, treat, cure, or prevent any disease.